All Columns articles – Page 56
-
OpinionCost reporting is more than worth it
The time for the chemical sector to report the environmental impact of its products is long overdue, says Michael Collins
-
Opinion
DNA waves don't wash
Philip Ball asks why a spectacular claim seems to have been overlooked. Sometimes science doesn’t work the way it’s supposed to
-
Opinion
The nonclassical cation: a classic case of conflict
Mark Peplow celebrates decades of debate about the structure of the 2-norbornyl cation
-
OpinionAn 'Aye' for details
Small steps by synthetic chemists could mean giant leaps for those who follow, says Karl Collins
-
OpinionA self-assembled periodic table
Philip Ball unpacks the instructions for a new periodic table
-
OpinionLab’s labourers lost?
How long should scientists stay at the bench, asks Derek Lowe. How long is a piece of string?
-
OpinionTarget acquired
Knowing a drug’s exact biochemistry has never been a prerequisite for approval, says Derek Lowe, and nor should it be
-
-
OpinionFlashback: 1988 – chemical weapon collaboration
Russian and British teams discuss chemical warfare as a step towards a ban
-
-
-
OpinionChange: the only constant
Jim Al-Khalili discusses the risks involved in switching to a new area of research and invites chemists to take a quantum biology leap
-
OpinionA carbon-based future
Society should be prepared to see its reliance on fossil fuels continue long into the 21st century, says Arno de Klerk
-
-
OpinionHelium reserves under pressure
Researchers should get ready for ballooning prices, warns Mark Peplow
-
-
Opinion
Pactamycin
Labelling a molecule 'inaccessible to synthesis' is a red rag to a bull, says Paul Docherty
-
OpinionCompulsory licences: necessity or threat?
Are compulsory licences for patent-protected drugs a necessary measure, or a threat to innovation?